Insights

Strategic Focus TTM Capital specializes in early and growth-stage investments in life science and healthcare, emphasizing biopharmaceuticals, medical devices, in vitro diagnostics, and medical+ solutions. For sales, this indicates potential opportunities to align offerings with their portfolio companies and funding rounds, particularly for technologies solving unmet medical needs and niche markets.

Active Growth Recent activity includes a Series A investment in RayThera, signaling ongoing interest in scalable biotech platforms. Outreach could target RayThera’s expansion plans or follow-on opportunities as they accelerate product development and market entry.

Global Collaboration TTM emphasizes linking industry resources, academia, government, and capital to accelerate medical innovation. This openness to strategic alliances presents openings for partnerships, co-development deals, and consortia opportunities with portfolio companies and research institutions.

Tech-Enabled Their tech stack includes major cloud and analytics tools (Google Cloud, Baidu Analytics, Tencent Exmail). This suggests receptivity to technology-driven VCs and the potential for data-enabled vendor solutions, digital health tools, and secure IT services to support portfolio companies.

Funding Readiness With revenue in the range of $10M–$25M and a focus on long-term, value-creating investments, TTM Capital is positioned for partner-ready opportunities such as bespoke growth capital, strategic financings, and cross-border fundraising assistance for life science ventures.

Similar companies to TTM Capital

TTM Capital Tech Stack

TTM Capital uses 8 technology products and services including Baidu Analytics, DNSPod, Tencent Exmail, and more. Explore TTM Capital's tech stack below.

  • Baidu Analytics
    Analytics
  • DNSPod
    Domain Name Services
  • Tencent Exmail
    Email
  • Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • Animate.css
    UI Frameworks
  • Bootstrap
    UI Frameworks
  • OpenResty
    Web Servers

TTM Capital's Email Address Formats

TTM Capital uses at least 1 email format:
TTM Capital Email FormatsExamplePercentage
Last@ttmcapital.comDoe@ttmcapital.com
100%

Frequently Asked Questions

What is TTM Capital's official website and social media links?

Minus sign iconPlus sign icon
TTM Capital's official website is ttmcapital.com and has social profiles on LinkedIn.

How much revenue does TTM Capital generate?

Minus sign iconPlus sign icon
As of September 2026, TTM Capital's annual revenue is estimated to be $10M - $25M.

What is TTM Capital's NAICS code?

Minus sign iconPlus sign icon
TTM Capital's NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does TTM Capital have currently?

Minus sign iconPlus sign icon
As of September 2026, TTM Capital has approximately 13 employees across 3 continents, including Asia, North America and Europe. Key team members include Founding Partner: Y. L., Director: X. J. and 合伙人: H. Y. Explore TTM Capital's employee directory with LeadIQ.

What industry does TTM Capital belong to?

Minus sign iconPlus sign icon
TTM Capital operates in the Venture Capital and Private Equity Principals industry.

What technology does TTM Capital use?

Minus sign iconPlus sign icon
TTM Capital's tech stack includes Baidu Analytics, DNSPod, Tencent Exmail, Google Cloud, jQuery, Animate.css, Bootstrap and OpenResty.

What is TTM Capital's email format?

Minus sign iconPlus sign icon
TTM Capital's email format typically follows the pattern of Last@ttmcapital.com. Find more TTM Capital email formats with LeadIQ.

When was TTM Capital founded?

Minus sign iconPlus sign icon
TTM Capital was founded in 2020.
TTM Capital logo

TTM Capital

Venture Capital and Private Equity PrincipalsShanghai, China11-50 Employees

TTM Capital is a professional investment firm established at the end of 2020, based in Shanghai, China, that focuses on early and growth-stage opportunities in life science and healthcare. Its work centers on biopharmaceuticals, medical devices, in vitro diagnostics, and related medical innovations, pursuing niche markets with unmet needs and aiming to support technologies that address significant patient and global health gaps. The firm positions itself as a connector across capital, enterprises, academia, and talent, emphasizing long-term collaboration and value creation for invested companies. In addition to its investment activity, TTM Capital describes a multi-disciplinary sourcing approach and strategic alliances designed to build ventures with technical and business expertise, seeking to enhance the potential for groundbreaking medical solutions. A recent development noted is the firm’s involvement in a Series A financing for RayThera, Inc., signaling continued participation in early-stage medical innovations through collaborations with other prominent investors.

Section iconCompany Overview

NAICS Code
52391 - Miscellaneous Intermediation
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    TTM Capital's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.